Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01474863 · ClinicalTrials.gov registry record · Phase 2
Citrulline in Severe Sepsis
A Phase 2 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 72
- Enrollment target
NCT01474863 is a Phase 2 study that has completed, run by Vanderbilt University. The registered enrollment target is 72 participants.
The verdict
NCT01474863, a Phase 2 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 72 participants
- Enrollment target
Study Summary
This is a randomized, double-blind, placebo-controlled, phase 2 study to evaluate biochemical, clinical, and safety effects of 2 doses of intravenous L-citrulline compared to placebo in patients with severe sepsis at risk for or with acute lung injury. The hypothesis is that intravenous L-citrulline will decreased the development or progression of acute lung injury in patients with severe sepsis compared to placebo.
Interventions
- DRUG Placebo
- DRUG High Dose Citrulline
- DRUG Low Dose Citrulline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2012-08 |
| Est. Completion | 2016-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01474863
The ClinicalTrials.gov registry entry for NCT01474863 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01474863 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01474863 about?
NCT01474863 is a clinical study titled "Citrulline in Severe Sepsis". This is a randomized, double-blind, placebo-controlled, phase 2 study to evaluate biochemical, clinical, and safety effects of 2 doses of intravenous L-citrulline compared to placebo in patients with severe sepsis at risk for or with acute lung injury. The hypothesis is that intravenous L-citrulline...
What is the current status of trial NCT01474863?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 72 participants. The study started on 2012-08. Estimated completion is 2016-03.
What interventions are being tested in trial NCT01474863?
The interventions under investigation include: Placebo (DRUG), High Dose Citrulline (DRUG), Low Dose Citrulline (DRUG).
Who is sponsoring clinical trial NCT01474863?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.